	Créanciers Commerciaux		Date
Acadia Pharmaceuticals	USD 21.75M	1.65M	2025-09
Alnylam Pharmaceuticals	USD 115.72M	1.87M	2025-12
Amgen	USD 20.89B	1.25B	2025-12
BioCryst Pharmaceuticals	USD 5.57M	3.02M	2025-09
Biogen	USD 432M	18.9M	2025-12
BioMarin Pharmaceutical	USD 798.44M	114.19M	2025-09
Cytokinetics	USD 22.08M	46.46M	2025-09
Daiichi Sankyo	JPY 568.5B	16.84B	2025-12
Enanta Pharmaceuticals	USD 1.88M	63K	2025-12
Esperion Therapeutics	USD 77.51M	2.81M	2025-09
Gilead Sciences	USD 808M	226M	2025-09
Incyte	USD 1.63B	1.46B	2025-12
Ionis Pharmaceuticals	USD 14.33M	8.47M	2025-09
Ironwood Pharmaceuticals	USD 1.61M	224K	2025-09
Karyopharm Therapeutics	USD 5.39M	2.8M	2025-09
Novartis	USD 4.56B	49M	2025-09
Pfizer	USD 5.02B	142M	2025-09
PTC Therapeutics	USD 36.62M	169.69M	2025-09
Puma Biotechnology	USD 6.39M	962K	2025-09
Roche Holding	CHF 5.78B	1.27B	2025-12
Sangamo BioSciences	USD 10.74M	7.46M	2025-06
Sarepta Therapeutics	USD 94.02M	42.69M	2025-09
TG Therapeutics	USD 61.64M	72.38M	2025-09
Ultragenyx Pharmaceutical	USD 40.57M	6.33M	2025-09
Vertex Pharmaceuticals	USD 3.43B	600.9M	2025-12
Xencor	USD 9.08M	9.45M	2025-09

PTC Therapeutics Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.